PharmaNews.eu
  • Home
  • Business
  • R&D
  • EC
  • EMA
  • Events
  • Open Calls

Pfizer

Pfizer

PfizerFounded in 1849, Pfizer is the world's largest research-based pharmaceutical company. Pfizer is taking new approaches to advancing better health as it discovers, develops, manufactures and delivers quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. Pfizer also partners with healthcare providers, governments and local communities around the world to expand access to medicines and to provide better quality health care and health system support. At Pfizer, more than 84,000 colleagues in more than 90 countries work every day to help people stay happier and healthier longer and to reduce the human and economic burden of disease worldwide. For more information visit www.pfizer.com.

Pfizer RSS Channel

Filters
List of articles in category Pfizer
Title Published Date
XELJANZ® (tofacitinib citrate) receives marketing authorisation in the European Union for the treatment of moderate to severe active rheumatoid arthritis 27 March 2017
IBM and Pfizer to accelerate immuno-oncology research with Watson for Drug Discovery 02 December 2016
Strengthening NHS research: Patients to access more new treatments through clinical trials 31 October 2013
Pfizer statement on PhRMA-EFPIA principles for responsible clinical trial data sharing 26 July 2013
ELIQUIS® (apixaban) receives CHMP positive opinion for the prevention of stroke and systemic embolism 21 September 2012
Pfizer receives EU marketing authorization for INLYTA® (Axitinib) 04 September 2012
European Medicines Agency accepts regulatory submission for bazedoxifene/conjugated estrogens 19 July 2012
Pfizer's Vyndaqel® (tafamidis) First Therapy Approved in the European Union 16 November 2011
Pfizer Receives European Approval to Extend Use of Prevenar 13 30 October 2011
Pfizer Announces EMA Acceptance of Regulatory Submissions 19 August 2011
Pfizer Conducts First "Virtual" Clinical Trial Allowing Patients to Participate Regardless of Geography 08 June 2011
Pfizer Files for European Regulatory Review of Axitinib 01 June 2011
ELIQUIS® (apixaban) Approved in Europe for Preventing Venous Thromboembolism after Elective Hip or Knee Replacement 21 May 2011
Pfizer Reports First-Quarter 2011 Results 03 May 2011
XIAPEX® Authorized in the European Union (EU) for Dupuytren's Contracture 28 February 2011
New AVERROES Data Demonstrate Investigational Apixaban Superior to Aspirin 13 February 2011
Pfizer and Protalix BioTherapeutics Announce Submission of taliglucerase alfa for European Marketing Authorization 29 November 2010
Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity 15 November 2010
Alpine Mountaineer and Alzheimer's Advocate to Climb Highest Peak on Each Continent 09 November 2010
Updated Pfizer Pipeline Focuses on Value, Unmet Medical Need 29 September 2010

Page 4 of 6

  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next
  • End
  1. You are here:  
  2. Home
  3. Pfizer

About

  • Home
  • Terms and Conditions
  • Contact

Advertise

Top News Channels

  • Business
  • Research
  • EMA
  • Events

Follow us

Didn't we got you connected? If not, please note the following magic buttons:

  • Facebook
  • Twitter
  • RSS 2.0
  • Atom 1.0

Newsletter

Stay updated on the latest Pharma News. Subscribe now, it's free!

Copyright © 2023 PharmaNews.eu. All Rights Reserved.